STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Avanos Medical (NYSE: AVNS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Michael Greiner, the company's interim chief executive officer, will deliver a presentation on Monday, January 13, at approximately 3:45 p.m. PST.

The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.58% News Effect

On the day this news was published, AVNS gained 0.58%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALPHARETTA, Ga., Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd  Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, Jan. 13, at approximately 3:45 p.m. PST.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc. Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302343007.html

SOURCE Avanos Medical, Inc.

FAQ

When is Avanos Medical (AVNS) presenting at the J.P. Morgan Healthcare Conference 2025?

Avanos Medical will present on Monday, January 13, 2025, at approximately 3:45 p.m. PST in San Francisco, California.

How can investors watch the Avanos Medical (AVNS) presentation at the JP Morgan Healthcare Conference?

Investors can watch the presentation via webcast through the Investors section of the Avanos Medical website, where it will also be archived.

Who will represent Avanos Medical (AVNS) at the 2025 J.P. Morgan Healthcare Conference?

Michael Greiner, interim chief executive officer of Avanos Medical, will present at the conference.

Which annual J.P. Morgan Healthcare Conference will Avanos Medical (AVNS) attend in 2025?

Avanos Medical will attend the 43rd Annual J.P. Morgan Healthcare Conference.
Avanos Medical

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Latest SEC Filings

AVNS Stock Data

549.14M
44.52M
4.07%
98.38%
5.89%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
ALPHARETTA